important data in the squamous nsclc population
Published 6 years ago • 89 plays • Length 4:18Download video MP4
Download video MP3
Similar videos
-
4:27
final thoughts on squamous nsclc research
-
5:10
the role of immunotherapy in squamous nsclc
-
5:30
diagnosis of locally-advanced squamous nsclc
-
4:52
the keynote-407 trial in metastatic squamous nsclc
-
0:54
dr. bestvina on the keynote-407 trial in squamous nsclc
-
7:42
immune checkpoint inhibitors in squamous non-small cell lung cancer
-
2:21
new data for in metastatic, squamous cell carcinoma of the lung
-
9:22
determining the optimal treatment in advanced non-squamous non-small cell lung cancer
-
5:00
implications for pembrolizumab in nsclc
-
4:56
options in second-line non-squamous nsclc
-
6:06
stage iii nsclc: when to start durvalumab
-
8:14
approaching non-driver stage iv nsclc
-
21:12
squamous cell carcinoma of the lung: treatment options in first- and second line
-
2:09
dr. subramanian on the impower131 trial in squamous nsclc
-
4:22
nivolumab in non-small cell lung cancer
-
6:14
understanding biomarker testing in non-small cell lung cancer
-
26:57
segment 2: molecular targets in nsclc
-
9:21
case based panel discussions - metastatic squamous nsclc low tumor pd-l1 frail patient - treatment?
-
1:03:21
incorporating ngs in an asian non-small cell lung cancer (nsclc) population -a cost-effectiveness...